Result of AGM

RNS Number : 8717V

Epistem Holdings plc

18 December 2013

 



Epistem Holdings Plc

("Epistem" or the "Company")

18 December 2013

Results of AGM

Epistem Holdings plc (LSE: EHP), the biotechnology and personalised medicine company, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

For further details please contact:

Epistem Holdings PLC
Matthew Walls, Chief Executive Officer	Tel: [phone]
John Rylands, Finance Director	Tel: [phone]
Walbrook PR	Tel: [phone]
Mike Wort/Anna Dunphy
Peel Hunt LLP	Tel: [phone]
James Steel

Notes to Editors:

About Epistem

Epistem is a biotechnology and personalised medicine company commercialising its expertise in epithelial stem cells and pharmacogenomics in the areas of oncology, gastrointestinal, dermatological and infectious disease.

Epistem develops innovative therapeutics, biomarkers and diagnostics alongside providing preclinical services to drug development companies. Epistem's core expertise is focused on the regulation of adult stem cells located in epithelial tissue which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. Epistem also has a range of proprietary amplification (RNA and DNA) technologies for use in drug discovery, development and diagnostics.

 

END

 

 

RAGFFDFEAFDSELE